MITF and breast cancer: The microphthalmia-associated transcription factor (MITF) is activated through O-GlcNAcylation by the O-GlcNAc transferase (OGT), which facilitates its translocation to the nucleus, thereby inhibiting senescence in palbociclib-induced breast cancer drug-resistant cells22.